Product/Composition:- | Sodium Zirconium Cyclosilicate(Ref.Brand:Lokelma®(EU & US) Generics |
---|---|
Strength:- | 5g 7 10 g sachets |
Form:- | Powder for oral suspension |
MOQ | MOQ |
Get Quote Send Enquiry on WhatsApp |
Sodium Zirconium Cyclosilicate (SZC), marketed as Lokelma®, is a fast-acting, selective potassium binder used to treat hyperkalemia in CKD and heart failure patients. Approved in the EU and US, it is supplied as a powder for oral suspension in 5 g and 10 g sachets.
Sodium Zirconium Cyclosilicate (SZC), marketed as Lokelma®, is a novel, highly selective potassium binder used to treat hyperkalemia in patients with chronic kidney disease, heart failure, or those on RAAS inhibitors. Approved by the FDA and EMA, it offers rapid onset and sustained potassium control with excellent tolerability. Available as a powder for oral suspension in 5 g and 10 g strengths, SZC is in high demand across EU and US pharmaceutical B2B markets. Ideal for licensing, distribution, and contract manufacturing partnerships, SZC represents a valuable addition to renal and cardiovascular therapeutic portfolios in regulated international markets.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications